Open AccessUpfront Magnetic Resonance Imaging-Guided Stereotactic Laser-Ablation in Newly Diagnosed Glioblastoma: A Multicenter Review of Survival Outcomes Compared to a Matched Cohort of Biopsy-Only Patients
Author(s) -
Alireza Mohammadi,
Mayur Sharma,
Thomas L. Beaumont,
Kevin O. Juarez,
Hanna Kemeny,
Cosette Dechant,
Andreas Seas,
Nehaw Sarmey,
Bryan S. Lee,
Jia Xing,
Peter E. Fecci,
Joachim M. Baehring,
Jennifer Moliterno,
Veronica Chiang,
Manmeet Ahluwalia,
Albert H. Kim,
Gene H. Barnett,
Eric C. Leuthardt
Publication year - 2018
Publication title -
neurosurgery/neurosurgery online
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.455
H-Index - 198
eISSN - 1081-1281
pISSN - 0148-396X
DOI - 10.1093/neuros/nyy449
Subject(s) - medicine , biopsy , cohort , stereotactic biopsy , radiation therapy , magnetic resonance imaging , radiology , oncology
Laser ablation (LA) is used as an upfront treatment in patients with deep seated newly diagnosed Glioblastoma (nGBM).